Category: Atypical AntipsychoticActive constituent: OlanzapineConcentrations: 5 mgIndications: SchizophreniaBipolar DisordersDose : once daily
Excellent control of Positive, Negative and Depressive symptomsBetter maintenance of response with improving quality of life
UPC
56 th queen farida st., al miraj city
New maadi
Cairo
Egypt
Phone: +202 26 17 61 85
Fax: +20224470563
Email: upc@egyupc.com
UPC is an Egyptian company operating in the pharmaceutical field since 1998 Dr.Yehia Saudi is the company CEO.